相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways
Sabrina Manni et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
Jahangir Abdi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Re-balance of memory T cell subsets in peripheral blood from patients with CML after TKI treatment
Danlin Yao et al.
ONCOTARGET (2017)
Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma
Djordje Atanackovic et al.
CURRENT CANCER DRUG TARGETS (2017)
Higher PD-1 expression concurrent with exhausted CD8+T cells in patients with de novo acute myeloid leukemia
Jiaxiong Tan et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities
Kate Roberts et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
Bone marrow microenvironmental CD4+and CD8+lymphocyte infiltration patterns define overall- and progression free survival in standard risk multiple myeloma - an analysis from the Austrian Myeloma Registry
Wolfgang Willenbacher et al.
LEUKEMIA & LYMPHOMA (2016)
T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy
David J. Chung et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts
Su Li Poh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
Claudia Zelle-Rieser et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model
Franz J. Gassner et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Guellue Goerguen et al.
CLINICAL CANCER RESEARCH (2015)
The failure of immune checkpoint blockade in multiple myeloma with PD-1 inhibitors in a phase 1 study
H. Suen et al.
LEUKEMIA (2015)
Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells
A. Ray et al.
LEUKEMIA (2015)
PD-1hiTIM-3+ T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation
Y. Kong et al.
BLOOD CANCER JOURNAL (2015)
Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
Weiqing Jing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma
D. Atanackovic et al.
LEUKEMIA (2014)
Immunological Dysregulation in Multiple Myeloma Microenvironment
Alessandra Romano et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
Li Shi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia
Claudia Mueller-Schmah et al.
ANNALS OF HEMATOLOGY (2012)
IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma
Zhi-Zhang Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade
William H. D. Hallett et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
Qing Zhou et al.
BLOOD (2011)
Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma
Yangqiu Li et al.
HEMATOLOGY (2011)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
Jochen Greiner et al.
CLINICAL CANCER RESEARCH (2008)
Immunodeficiency and immunotherapy in multiple myeloma
Guy Pratt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
分享论文
